MiNK Therapeutics, Inc. (INKT) Tops Q2 EPS by 3c

MiNK Therapeutics, Inc. (NASDAQ: INKT) reported Q2 EPS of ($0.07), $0.03 better than the analyst estimate of ($0.10).

For earnings history and earnings-related data on MiNK Therapeutics, Inc. (INKT) click here.

You May Also Be Interested In

• X Financial (XYF) Tops Q2 EPS by 438c
• Chicago Fed Nat Activity Index (Jul) -0.08% vs -0.09 Expected
• Better Home & Finance board backs interim CEO amid founder dispute